Dextech Medical Market Risk Adjusted Performance
| LQ0 Stock | | | 0.89 -0.03 -3.26% |
Observed values used to calculate the Market Risk Adjusted Performance technical indicator for Dextech Medical AB. Certain instruments may report limited data depending on market coverage.
Dextech Medical AB has current Market Risk Adjusted Performance of 0.7052.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | 0.7052 | |
| ER[a] | = | Expected return on investing in Dextech Medical |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Dextech Medical Market Risk Adjusted Performance Peers Comparison
Dextech Market Risk Adjusted Performance Relative To Other Indicators
Dextech Medical AB ranks
third among stocks in market risk adjusted performance across its competitive set. It is currently under evaluation in maximum drawdown across its competitive set at roughly
41.25 Maximum Drawdown per unit of Market Risk Adjusted Performance. Dextech Medical AB carries a
41.25 x Maximum Drawdown-to-Market Risk Adjusted Performance ratio
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.